Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions
Authors
Keywords
-
Journal
Lancet Haematology
Volume 8, Issue 8, Pages e593-e604
Publisher
Elsevier BV
Online
2021-07-28
DOI
10.1016/s2352-3026(21)00167-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multifocal leukoencephalopathy treated with nivolumab
- (2019) Ethan Hoang et al. JOURNAL OF NEUROVIROLOGY
- Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
- (2019) Irene Cortese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can Immune Checkpoint Inhibitors Keep JC Virus in Check?
- (2019) Igor J. Koralnik NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab
- (2019) Sebastian Rauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab
- (2019) Ondine Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
- (2018) Ahmed Boumediene et al. JOURNAL OF AUTOIMMUNITY
- Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event
- (2018) Joseph R. Berger et al. JOURNAL OF NEUROVIROLOGY
- Allogeneic BK Virus–Specific T Cells for Progressive Multifocal Leukoencephalopathy
- (2018) Muharrem Muftuoglu et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
- (2017) Antonio Carotenuto et al. JOURNAL OF NEUROIMMUNOLOGY
- Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine
- (2017) Vaishali Suri et al. NEUROLOGY INDIA
- Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system
- (2016) Dennis W. Raisch et al. Expert Opinion On Drug Safety
- Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma
- (2015) Tsutsumi Yutaka et al. LEUKEMIA & LYMPHOMA
- Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab
- (2015) Silvia Piantoni et al. RHEUMATOLOGY INTERNATIONAL
- Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1
- (2014) Mireia Sospedra et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7
- (2014) Karl B. Alstadhaug et al. JAMA Neurology
- Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era
- (2013) J. L. Casado et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
- (2013) Rowan Wathes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy
- (2012) Chen Sabrina Tan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy
- (2010) M. Tuccori et al. ONCOLOGIST
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Detection of JC Virus DNA and Proteins in the Bone Marrow of HIV‐Positive and HIV‐Negative Patients: Implications for Viral Latency and Neurotropic Transformation
- (2009) Chen S. Tan et al. JOURNAL OF INFECTIOUS DISEASES
- Re: Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized trials
- (2009) Marco Tuccori et al. JNCI-Journal of the National Cancer Institute
- Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy
- (2009) Guillaume Lefèvre et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- PML-IRIS in patients with HIV infection: Clinical manifestations and treatment with steroids
- (2009) K. Tan et al. NEUROLOGY
- Detection of JC virus DNA fragments but not proteins in normal brain tissue
- (2008) Georgina Perez-Liz et al. ANNALS OF NEUROLOGY
- Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness
- (2008) Emma Guttman-Yassky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The role of polyomaviruses in human disease
- (2008) Mengxi Jiang et al. VIROLOGY
- Efalizumab Therapy for Atopic Dermatitis Causes Marked Increases in Circulating Effector Memory CD4+ T Cells That Express Cutaneous Lymphocyte Antigen
- (2007) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started